← SynDRA
ABIVERTINIB
SynDRA canonical compound SYN0039763 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | EGFR |
|---|
| Mechanism of action | EGFR inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- EGFR INHIBITOR
- Epidermal growth factor receptor erbB1 inhibitor
- BTK INHIBITOR
- Tyrosine-protein kinase BTK inhibitor
- JAK3 INHIBITOR
Cross-references
Synonyms
- AC0010
- Avitinib
- A610
- AC-0010
- ACEA100610
- EX-ACEA0010
- N-(3-((2-((3-Fluoro-4-(4-methylpiperazin-1-yl)phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenyl)acrylamide
- Avitinib free base
- SCHEMBL15453394
- KS-00000TON
- EX-A783
- MolPort-042-663-560
- Avitinib(AC0010/AC0010MA)
- ZINC142081723
- AKOS030632728
- CS-W008904
- N-(3-{2-[3-Fluoro-4-(4-methyl-piperazin-1-yl)-phenylamino]-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy}-phenyl)-acrylamide
- DS-19269
- AK543905
- 2-Propenamide, N-[3-[[2-[[3-fluoro-4-(4-methyl-1-piperazinyl)phenyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-
- CER0OPG92L
- AC 0010
- abivertinibum
- RefChem:108536
- EXACEA0010MA
- AC-0010 maleate dihydrate
- STI5656
- Avitinib (AC0010)
- Abivertinib [USAN]
- MFCD29089376
- Abivertinib (USAN)
- YKQ
- Avitinib free base?
- FUJOVEE
- UNII-CER0OPG92L
- ABIVERTINIB [INN]
- avitinib (superceded INN)
- AVITINIB [WHO-DD]
- ABIVERTINIB [WHO-DD]
Look up ABIVERTINIB in the interactive SynDRA portal →